The reverse acquisition terms imply severe dilution for current SHF holders, with Opifex controlling 85% of the combined entity. The non-binding term sheet and need for Series B holder consents, audited Opifex financials, and Nasdaq approval create significant execution risk. Monitor for definitive agreement and stockholder vote timeline.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Oct 26 $0.0940entry
- T+1 · 21d ago +23.19%α +22.63% · $0.1158
- T+5 · 15d ago −50.85%α −49.12% · $0.0462
- T+15 · todayOpen
- T+20 · in 6d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SHF Holdings (Safe Harbor) filed a DEFA14A disclosing a non-binding term sheet for a reverse acquisition of Opifex Media, a creator-economy holding company. Existing SHF stakeholders would own 15% of the combined entity (adjustable 12.5%-17.5%), implying massive dilution. Separately, SHF issued 23,914,988 shares via Series B Preferred conversions during Q3 2026, increasing share count to 24,942,735 as of Oct 23, 2026.
Key Facts
- SHF entered a non-binding term sheet for a reverse acquisition by Opifex Media; Opifex holders would own 85% of the combined company, SHF stakeholders 15% (range 12.5%-17.5%).
- Opifex valuation floor is $50 million, subject to independent valuation and fairness opinion.
- SHF issued 23,914,988 common shares upon conversion of 6,545 Series B Preferred shares from July 1 to Oct 23, 2026, at an average conversion price of $0.2737.
- As of Oct 23, 2026, SHF had 24,942,735 common shares outstanding, the conversions alone nearly doubled the share count from an undisclosed June 30 base.
- Nasdaq granted SHF a second 180-day compliance period through April 19, 2027, to meet the $1.00 minimum bid price requirement.
- The term sheet includes a contingent value right for SHF stakeholders related to the cannabis financial services business.
- SHF does not intend to draw on its CREO Capital equity line until closing of the proposed transaction.
Financial Impact
Existing SHF stakeholders diluted to 15% ownership (12.5%-17.5% range) of the combined company; 23.9M shares issued in Q3 2026 conversions, increasing outstanding shares to 24.9M.
Risk Factors
- Massive dilution: existing SHF stakeholders reduced to 12.5%-17.5% of combined company.
- Non-binding term sheet, no assurance of definitive agreement or closing.
- Opifex must deliver audited financials and complete pending acquisitions; failure could scuttle the deal.
- SHF faces Nasdaq delisting risk if bid price compliance not regained by April 19, 2027.
- Series B Preferred holders must consent to conversion arrangements; failure blocks the transaction.
- Reverse stock split needed to meet Nasdaq bid price requirement, which may further pressure the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001493152-26-048427 |
| Exhibit: ex99-1.htm | 0001493152-26-048427 |
| Document: 0001493152-26-048427-index-headers.html | 0001493152-26-048427 |
| Document: 0001493152-26-048427-index.html | 0001493152-26-048427 |
| Document: 0001493152-26-048427.txt | 0001493152-26-048427 |
Track record
27 reports on SHFS
12 of 15 bullish or bearish reports moved the stock their way by T+5. Best: +98.49% at T+60 after the Aug 11, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 13, 20263d ago S-1 Bearish 7/10 Entry $0.0277 Now $0.0230 +16.97% settles Nov 23
- Nov 13, 20263d ago DEFA14A Bearish 7/10 Entry $0.0280 Now $0.0230 +17.86% settles Nov 23
- Nov 12, 20264d ago 425 Bearish 7/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
- Nov 12, 20264d ago 8-K Bearish 9/10 Entry $0.0303 Now $0.0230 +24.09% settles Nov 20
- Nov 9, 20267d ago DEFA14A Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago 425 Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago 8-K Bearish 7/10 No price data
- Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Nov 9, 20267d ago Press Release Bearish 7/10 Entry $0.0248 to $0.0230 Now $0.0230 +7.26% ▲ +7.26% +5.57% vs SPY
- Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.0462 to $0.0248 Now $0.0230 +50.22% ▲ +46.32% +46.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers